Old Point Trust & Financial Services N A Zosano Pharma Corp Call Options Transaction History

Old Point Trust & Financial Services N A

  • $272 Million
  • Q3 2024

Call Options

0 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
No transaction found.

Others Institutions Holding ZSANQ

# of Institutions
1
Shares Held
28
Call Options Held
0
Put Options Held
0
View Full List

About Zosano Pharma Corp

ZSANQ Quotes by TradingView
  • Ticker ZSANQ
  • Exchange OTC
  • Shares Outstandng 4,902,260
  • Description
  • Zosano Pharma Corporation, a clinical stage biopharmaceutical company, focuses on providing therapeutics and other bioactive molecules to patients suffering from migraine using its transdermal microneedle system. Its lead product candidate is Qtrypta (M207), a proprietary formulation of zolmitriptan used for the acute treatment of migraine. The ...
More about ZSANQ
Track This Portfolio

Track Old Point Trust & Financial Services N A Portfolio

Follow Old Point Trust & Financial Services N A and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Old Point Trust & Financial Services N A, based on Form 13F filings with the SEC.

News

Stay updated on Old Point Trust & Financial Services N A with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email